Evacim

Bevacizumab

Evacim actero pharma

Category:

Biologic

Biologic

Oral

Oral

Dosage form :

Vials

Doses :

100/400 mg

Short Description:

Evacim contains the active substance bevacizumab, which is a humanised monoclonal antibody. Evacim binds selectively to a protein called human vascular endothelial growth factor (VEGF), which is found on the lining of blood and lymph vessels in the body. The VEGF protein causes blood vessels to grow within tumours, these blood vessels provide the tumour with nutrients and oxygen. Once bevacizumab is bound to VEGF, tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and oxygen to the tumour.

Product Introduction

Rituximab

Biologic

Biologic

Injectable

Injectable